Indo Rama Synthetics FY26 profit surges on cost cuts
Indo Rama Synthetics (India) Limited reported a consolidated net profit of ₹150.21 crore for FY26, a sharp increase from ₹1.40 crore in the previous year, supported by a 13.39% EBITDA margin in Q4. The board approved the audited results on May 25, 2026, but did not declare a dividend for the year. The company appointed internal and cost auditors for FY27 and scheduled its 40th AGM for September 8, 2026.

*this image is generated using AI for illustrative purposes only.
Indo Rama Synthetics (India) Limited reported a consolidated net profit of ₹150.21 crore for the financial year ended March 31, 2026, a significant increase from ₹1.40 crore in the previous year. The company's board approved the audited standalone and consolidated financial results for the quarter and year ended March 31, 2026, at a meeting held on May 25, 2026. Despite the profitability, the board stated that the company is unable to declare a dividend for FY26 based on the financial results.
The audit reports for both standalone and consolidated financial results were submitted with unmodified opinions. M/s S S Kothari Mehta & Co. LLP, the statutory auditors, confirmed the unmodified opinion in their report pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company published the extract of these audited financial results in Business Standard (all India Edition, English) and Loksatta (Nagpur edition, Marathi) on May 26, 2026, in accordance with Regulation 47 (1) (b) of SEBI (LODR) Regulations, 2015.
Financial Performance
For the quarter ended March 31, 2026, the company reported a consolidated net profit of ₹64.13 crore, compared to ₹51.07 crore in the same period of the previous year. Q4 revenue stood at 12b Rupees versus 11.98b Rupees in the same quarter of the previous year. Q4 EBITDA came in at 1.6b Rupees compared to 770m Rupees in the year-ago period, while EBITDA margin expanded sharply to 13.39% from 6.42%, reflecting the impact of aggressive cost-cutting measures and improved market conditions. For the full year FY26, total income increased by 14.94% to ₹4,929.01 crore, and EBITDA grew to ₹368.25 crore from ₹207.99 crore in FY25.
The table below summarises the key consolidated financial metrics for the quarter and full year:
| Particulars: | Q4 FY26 | Q4 FY25 | FY26 | FY25 |
|---|---|---|---|---|
| Revenue | 12b Rupees | 11.98b Rupees | ₹4,929.01 crore | — |
| EBITDA | 1.6b Rupees | 770m Rupees | ₹368.25 crore | ₹207.99 crore |
| EBITDA Margin (%) | 13.39% | 6.42% | — | — |
| Net Profit | ₹64.13 crore | ₹51.07 crore | ₹150.21 crore | ₹1.40 crore |
The standalone financial results showed a net profit of ₹110.03 crore for FY26, compared to ₹20.08 crore in the previous year. Revenue from operations for the year stood at ₹4,518.73 crore. The company recorded an exceptional item of ₹2.69 crore related to employee benefit expenses due to the implementation of new labour codes.
Auditor Appointments and AGM
The board approved the appointment of M/s Deloitte Haskins & Sells LLP as Internal Auditors for the financial year 2026-27. The firm was appointed for a one-year term effective May 25, 2026. Additionally, Mr. R. Krishnan was re-appointed as the Cost Auditor for the financial year 2026-27 for a one-year term starting May 25, 2026.
The 40th Annual General Meeting has been scheduled for Tuesday, September 8, 2026. The meeting will be conducted through Video Conferencing/OAVM facility, subject to relevant MCA and SEBI circulars and regulations.
Historical Stock Returns for Indo Rama Synthetics
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -5.60% | +18.89% | +10.15% | -20.11% | -8.32% | -21.02% |
What are the company's strategic plans for utilizing the surge in profitability to potentially resume dividend payouts in future fiscal years?
How sustainable are the current EBITDA margin improvements given the reliance on aggressive cost-cutting measures versus organic revenue growth?
What specific capital allocation priorities or expansion projects will management focus on in FY27 following the significant turnaround in financial performance?


































